Literature DB >> 17631292

Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1.

Andrew D Kraft1, Jon M Resch, Delinda A Johnson, Jeffrey A Johnson.   

Abstract

Oxidative stress plays a key role in the neuronal loss exhibited in amyotrophic lateral sclerosis (ALS), an event precipitating irreversible muscle atrophy. By crossing ALS mouse models (SOD(G93A) and SOD(H46RH48Q)) with an antioxidant response element (ARE) reporter mouse, we identified activation characteristics of the ARE system throughout the timecourse of motor neuron disease. Surprisingly, the earliest and most significant activation of this genetic sensor of oxidative stress occurred in the distal muscles of mutant SOD mice. The resultant data supports existing hypotheses that the muscle is somehow implicated during the initial pathology of these mice. Subsequently, Nrf2-ARE activation appears to progress in a retrograde fashion along the motor pathway. These data provide timely information concerning the contributions of the Nrf2-ARE pathway in ALS disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631292      PMCID: PMC2062571          DOI: 10.1016/j.expneurol.2007.05.026

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  54 in total

1.  Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE).

Authors:  T Prestera; P Talalay; J Alam; Y I Ahn; P J Lee; A M Choi
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

2.  Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis.

Authors:  Z E Enayat; R W Orrell; A Claus; A Ludolph; R Bachus; J Brockmüller; K Ray-Chaudhuri; A Radunovic; C Shaw; J Wilkinson
Journal:  Hum Mol Genet       Date:  1995-07       Impact factor: 6.150

3.  Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  P K Andrus; T J Fleck; M E Gurney; E D Hall
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

4.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

5.  Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study.

Authors:  P F Kennel; F Finiels; F Revah; J Mallet
Journal:  Neuroreport       Date:  1996-05-31       Impact factor: 1.837

6.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

7.  Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS.

Authors:  M Aoki; M Ogasawara; Y Matsubara; K Narisawa; S Nakamura; Y Itoyama; K Abe
Journal:  J Neurol Sci       Date:  1994-10       Impact factor: 3.181

8.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

Authors:  E D Hall; J A Oostveen; M E Gurney
Journal:  Glia       Date:  1998-07       Impact factor: 7.452

9.  Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).

Authors:  M C Dal Canto; M E Gurney
Journal:  Brain Res       Date:  1995-04-03       Impact factor: 3.252

10.  Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.

Authors:  E D Hall; P K Andrus; J A Oostveen; T J Fleck; M E Gurney
Journal:  J Neurosci Res       Date:  1998-07-01       Impact factor: 4.164

View more
  36 in total

Review 1.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

2.  RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Authors:  Nadine Bakkar; Arianna Kousari; Tina Kovalik; Yang Li; Robert Bowser
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

3.  Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo.

Authors:  Darren M Miller; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  Free Radic Biol Med       Date:  2012-12-27       Impact factor: 7.376

Review 4.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 5.  The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Gururaj Joshi; Jeffrey A Johnson
Journal:  Recent Pat CNS Drug Discov       Date:  2012-12

Review 6.  Stress-activated cap'n'collar transcription factors in aging and human disease.

Authors:  Gerasimos P Sykiotis; Dirk Bohmann
Journal:  Sci Signal       Date:  2010-03-09       Impact factor: 8.192

7.  Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.

Authors:  Tracy P Williamson; Delinda A Johnson; Jeffrey A Johnson
Journal:  Neurotoxicology       Date:  2012-02-09       Impact factor: 4.294

8.  Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Yan Su Guo; Dong Xia Wu; Hong Ran Wu; Shu Yu Wu; Cheng Yang; Bin Li; Hui Bu; Yue Sheng Zhang; Chun Yan Li
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

Review 9.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

10.  Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis.

Authors:  Daniel Bergemalm; Karin Forsberg; P Andreas Jonsson; Karin S Graffmo; Thomas Brännström; Peter M Andersen; Henrik Antti; Stefan L Marklund
Journal:  Mol Cell Proteomics       Date:  2009-04-08       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.